168 related articles for article (PubMed ID: 28330883)
1. Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.
Siopi M; Pournaras S; Meletiadis J
J Clin Microbiol; 2017 Jun; 55(6):1714-1719. PubMed ID: 28330883
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.
Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskov A; Ramani R
J Clin Microbiol; 2008 Jul; 46(7):2155-9. PubMed ID: 18463213
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
Wang HC; Hsieh MI; Choi PC; Wu CJ
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2009 Oct; 47(10):3323-5. PubMed ID: 19710267
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
Antimicrob Agents Chemother; 2008 Jan; 52(1):321-8. PubMed ID: 17938191
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.
Martos AI; Martín-Mazuelos E; Romero A; Serrano C; González T; Almeida C; Puche B; Cantón E; Pemán J; Espinel-Ingroff A
Diagn Microbiol Infect Dis; 2012 May; 73(1):53-6. PubMed ID: 22480568
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
Pfaller MA; Duncanson F; Messer SA; Moet GJ; Jones RN; Castanheira M
Antimicrob Agents Chemother; 2011 Nov; 55(11):5155-8. PubMed ID: 21844312
[TBL] [Abstract][Full Text] [Related]
9. Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria.
Aigner M; Erbeznik T; Gschwentner M; Lass-Flörl C
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559257
[No Abstract] [Full Text] [Related]
10. Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.
Martos AI; Romero A; González MT; González A; Serrano C; Castro C; Pemán J; Cantón E; Martín-Mazuelos E
Med Mycol; 2010 Sep; 48(6):858-61. PubMed ID: 20144131
[TBL] [Abstract][Full Text] [Related]
11. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M
J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
[TBL] [Abstract][Full Text] [Related]
12. Development and multicentre validation of an agar-based screening method for echinocandin susceptibility testing of Aspergillus species.
Meletiadis J; Siopi M; Kanioura L; Jørgensen KM; Perlin DS; Mouton JW; Arendrup MC
J Antimicrob Chemother; 2019 Aug; 74(8):2247-2254. PubMed ID: 31106352
[TBL] [Abstract][Full Text] [Related]
13. Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
Wiederhold NP; Locke JB; Daruwala P; Bartizal K
J Antimicrob Chemother; 2018 Nov; 73(11):3063-3067. PubMed ID: 30032217
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin Etest endpoint for Aspergillus isolates shows poor agreement with the reference minimum effective concentration.
Fuller J; Schofield A; Jiwa S; Sand C; Jansen B; Rennie R
J Clin Microbiol; 2010 Feb; 48(2):479-82. PubMed ID: 20007389
[TBL] [Abstract][Full Text] [Related]
15. Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
Diagn Microbiol Infect Dis; 2010 May; 67(1):56-60. PubMed ID: 20207095
[TBL] [Abstract][Full Text] [Related]
16. Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
Espinel-Ingroff A; Fothergill A; Fuller J; Johnson E; Pelaez T; Turnidge J
Antimicrob Agents Chemother; 2011 Jun; 55(6):2855-9. PubMed ID: 21422219
[TBL] [Abstract][Full Text] [Related]
17. Concentration-dependent effects of caspofungin on the metabolic activity of Aspergillus species.
Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
Antimicrob Agents Chemother; 2007 Mar; 51(3):881-7. PubMed ID: 17145783
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
Espinel-Ingroff A
J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp.
Castro C; Serrano MC; Flores B; Espinel-Ingroff A; Martín-Mazuelos E
J Clin Microbiol; 2004 Sep; 42(9):4358-60. PubMed ID: 15365044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
